Sequoia Vaccines, Inc. (SQVI)

Sequoia Vaccines was planning to go public, but the IPO was withdrawn on May 5, 2025.

IPO Price Range

$8.00 - $10.00

Shares Offered

2,775,000

Deal Size

$24.98M

Sequoia Vaccines Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Income	-3.12	-4.09	-6.38
Net Income	-4.49	-5.33	-7.08

Fiscal Year	Current	FY 2022	FY 2021
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.71	0.31	2.22
Total Debt	1.07	1.14	1.21
Net Cash (Debt)	-0.36	-0.83	1.02
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-2.92	-3.99	-1.71
Capital Expenditures	-0.01	-0.01	-0.01
Free Cash Flow	-2.93	-3.99	-1.71
Free Cash Flow Growth	-	-	-